Form 4 for EVH Evolent Health, Inc.
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001628908-21-000146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-03 | 2021-11-01 | EVH | Sotunde Tunde | Dir | A - Grant | $0.00 | +3,405 | 3,405 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-11-01 | A | A | 3,405 | $0.00 | 3,405 | D | — | — | (F1) Represents restricted stock units granted to Dr. Sotunde pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. (F2) Securities vest on the earlier of November 1, 2022 and the date of the company's 2022 annual meeting, subject to the reporting person's continued service on the vesting date. |